Leading Growth Driver in the Personalized Cell Therapy Market in 2025: Rising Neurological Disorders Fuel Growth In The Personalized Cell Therapy Market Driver's Influence

What industry-specific factors are fueling the growth of the personalized cell therapy market?
An increase in neurological disorders is anticipated to spur the expansion of the personalized cell therapy market. Neurological disorders constitute a group of conditions that impact the brain, spinal cord, and nerves, causing symptoms such as motor function impairment, cognitive deficits, and sensory disturbances. These disorders are becoming more prevalent due to factors like aging populations, environmental stress, and lifestyle modifications, leading to higher rates of neurodegenerative diseases. Personalized cell therapy, which provides treatment tailored to the specific needs of each patient, is essential for neurological disorders. These therapies potentially repair damaged neural tissue and enhance outcomes for complicated, individualized conditions. As an example, the Parkinson Foundation, a US government organization, reported in December 2022 that the annual incidence of Parkinson's disease among the elderly is now 50% higher than the existing estimate of 60,000 cases. Moreover, by 2030, an additional 1.2 million Americans are expected to suffer from Parkinson's disease. Hence, the escalation in neurological disorders is fueling the growth of the personalized cell therapy market.

Get Your Personalized Cell Therapy Market Report Here:
https://www.thebusinessresearchcompany.com/report/personalized-cell-therapy-global-market-report

What Is the projected market size and growth rate for the personalized cell therapy market?
The market size for personalized cell therapy has witnessed significant expansion in the past few years. The market, worth $17.11 billion in 2024, is projected to escalate to $21 billion in 2025, with a compound annual growth rate (CAGR) of 22.8%. The substantial growth during the historic period can be linked to a growing consciousness about personalized medicine, increased spending on healthcare, escalated government initiatives, more allocation of financial resources for clinical research, and an uptick in neurological disorders.

In the coming years, the market size for personalized cell therapy is predicted to experience remarkable growth, with projections suggesting it could reach $47.14 billion by 2029, boasting a compound annual growth rate (CAGR) of 22.4%. The anticipated growth during this forecast period is linked to an increase in clinical trials, a higher frequency of chronic diseases, an expanding elderly population, growing cancer rates, and a rise in the acceptance of regenerative medicines. The forecast period is also expected to encounter significant trends such as technological progress, the incorporation of AI, personalized vaccines, the use of bioinformatics, and developments in microfluidic technologies.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19137&type=smp

What new trends are reshaping the personalized cell therapy market and its opportunities?
The personalized cell therapy market is witnessing a trend where key players are teaming up to speed up the advancement and market release of ground-breaking treatments. These alliances allow companies to merge their resources, knowledge, and technologies to boost their research and development skills, expedite clinical testing, and navigate regulatory procedures more competently. For instance, US-based biotech firm Century Therapeutics Inc. joined forces with the US-based biopharmaceutical company Bristol Myers Squibb (BMS) in October 2022 for the development and commercialization of allogeneic cell therapies. Bristol Myers Squibb is leveraging Century's pioneering induced pluripotent stem cell (iPSC) technology to fabricate engineered natural killer (NK) and T cell therapies for treating hematologic malignancies and solid tumors. Included in the agreement is the development of as many as four separate cell therapy programs, initially majoring in two areas: acute myeloid leukemia (AML) and multiple myeloma. The different programs will involve the use of engineered NK cells or gamma delta T cells originating from iPSCs.

What major market segments define the scope and growth of the personalized cell therapy market?
The personalized cell therapymarket covered in this report is segmented -

1) By Cell Type: Lymphocytes, Mesenchymal Stem Cell, Hematopoietic Stem Cell, Other Cell Type
2) By Technique: Platelet Transfusions, Bone Marrow Transplantation, Packed Red Cell Transfusions, Organ Transplantation
3) By Application: Cardiovascular Diseases, Neurological Disorders, Inflammatory Diseases, Diabetes, Cancer, Other Applications
4) By End-User: Hospital, Homecare, Specialty Clinics, Other End-User

Subsegments:
1) By Lymphocytes: T Cells, Natural Killer (NK) Cells, Regulatory T Cells
2) By Mesenchymal Stem Cells (MSCs): Bone Marrow-Derived MSCs, Adipose Tissue-Derived MSCs, Umbilical Cord-Derived MSCs
3) By Hematopoietic Stem Cells: Autologous Hematopoietic Stem Cells, Allogeneic Hematopoietic Stem Cells
4) By Other Cell Types: Dendritic Cells, Fibroblasts, Endothelial Cells

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19137

What regions are at the forefront of personalized cell therapy market expansion?
North America was the largest region in the personalized cell therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized cell therapy marker report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which key market leaders are driving the personalized cell therapy industry growth?
Major companies operating in the personalized cell therapy marker are AbbVie Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Gilead Sciences Inc., Cipla Limited, Poseida Therapeutics Inc., Sangamo Therapeutics Inc., Nkarta Therapeutics Inc., Intellia Therapeutics Inc., Tessa Therapeutics Pte Ltd., Atara Biotherapeutics Inc., Adaptimmune Therapeutics plc, Precision BioSciences Inc., Editas Medicine Inc., Cellectis S.A., Gracell Biotechnologies Inc., Mesoblast Limited, Fate Therapeutics Inc., Athersys Inc., Bellicum Pharmaceuticals Inc., Celyad Oncology SA, Century Therapeutics Inc., Gamida Cell Ltd., CRISPR Therapeutics AG, Allogene Therapeutics Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=19137&type=smp

What Is Covered In The Personalized Cell Therapy Global Market Report?

•Market Size Forecast: Examine the personalized cell therapy market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the personalized cell therapy market for a structured understanding.
•Key Players Overview: Analyze major players in the personalized cell therapy market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the personalized cell therapy market.
•Segment Contributions: Evaluate how different segments drive overall growth in the personalized cell therapy market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the personalized cell therapy market.
•Industry Challenges: Identify potential risks and obstacles affecting the personalized cell therapy market.
•Competitive Landscape: Review strategic developments in the personalized cell therapy market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.